The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Asiafocus Regulatory News (AAS)

Share Price Information for Abrdn Asiafocus (AAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 276.00
Bid: 274.00
Ask: 276.00
Change: 5.00 (1.85%)
Spread: 2.00 (0.73%)
Open: 272.00
High: 276.00
Low: 272.00
Prev. Close: 271.00
AAS Live PriceLast checked at -
abrdn Asia Focus is an Investment Trust

To maximise long-term total return from a portfolio made up predominantly of smaller quoted companies (with a market cap of up to approximately USD 1.5bn at the time of investment) in the economies of Asia and Australasia, ex Japan.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting

27 Jan 2022 11:25

RNS Number : 8754Z
Aberdeen Standard Asia Focus PLC
27 January 2022
 

27 January 2022

Aberdeen Standard Asia Focus PLC

LEI: 5493000FBZP1J92OQY70

 

Results of General Meeting

 

Aberdeen Standard Asia Focus PLC (the "Company") announces that at the General Meeting held earlier today all resolutions proposed were duly passed by way of a poll. The votes received in relation to the resolutions were as follows:

RES NO. 

VOTESFOR

%

VOTESAGAINST

%

VOTESTOTAL

% of ISC VOTED

VOTESWITHHELD

01

17,180,764

99.91%

15,223

0.09%

17,195,987

54.78

12,983

02

17,138,547

99.73%

45,733

0.27%

17,184,280

54.74

24,690

03

17,160,049

99.84%

28,140

0.16%

17,188,189

54.76

20,781

04

16,318,008

94.93%

872,190

5.07%

17,190,198

54.76

18,772

 

The full text of all the resolutions can be found in the shareholder circular dated 11 January 2022, copies of which are available for viewing on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website, https://www.asia-focus.co.uk .

Following approval of the resolutions, changes to the Company's Investment Policy as outlined in the Shareholder Circular will be adopted with immediate effect.

As set out in the Notice of Meeting, Resolution 3, in relation to the sub-division of the Existing Ordinary Shares shall take effect on admission of the New Ordinary Shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities expected at 8.00 am on 4 February 2022. The New Ordinary Shares will rank pari passu with each other and will carry the same rights and be subject to the same restrictions as the Existing Ordinary Shares, including the same rights to participate in dividends paid by the Company. Communication preferences and mandates and other instructions for the payment of dividends in paper form or via CREST will, unless and until revised, continue to apply to the New Ordinary Shares. The expected timetable for the Share Split is set out below.

Under the Trust Deed, the conversion price of the CULS will be automatically and pro rata adjusted. The current conversion price is 1465.0p of CULS for one Existing Ordinary Share, and this shall change to a conversion price of 293.0p of CULS for one New Ordinary Share.

 

Expected timetable for the Share Split

Last day for dealings in Existing Ordinary Shares

Thursday 3 February

Record date for the Share Split and disablement in CREST of the existing ISIN for settlement

6.00 p.m. on Thursday, 3 February

Listing and Admission in the New Ordinary Shares expected to commence

8.00 am on Friday 4 February

Expected date for crediting CREST accounts with New Ordinary Shares (where applicable)

On or soon after 8.00 am on Friday 4 February

Expected date by which certificates in respect of New Ordinary Shares are to be dispatched to certificated shareholders

By Friday 18 February

 

Notes:

1. References to times in this document are to London time.

2. The dates set out in the expected timetable may be adjusted by the Company, in which event details of the new dates will be notified to Shareholders by an announcement made by the Company through a Regulatory Information Service.

 

 

For further information

abrdn

William Hemmings +44 (0)20 7463 6223

Stephanie Hocking +44 (0)20 7463 6403

 

Panmure Gordon

Sapna Shah +44 (0)20 7886 2783

Alex Collins +44 (0)20 7886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBBGDBSDDDGDR
Date   Source Headline
30th Apr 202412:55 pmRNSNet Asset Value(s)
30th Apr 202411:20 amRNSGearing disclosure
29th Apr 202412:38 pmRNSNet Asset Value(s)
26th Apr 20245:23 pmRNSTransaction in Own Shares
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 20245:41 pmRNSTransaction in Own Shares
24th Apr 20245:07 pmRNSCULS Interest Payment Date
24th Apr 20245:06 pmRNSCULS Conversion Notice
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 20245:15 pmRNSTransaction in Own Shares
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:21 pmRNSNet Asset Value(s)
19th Apr 202412:46 pmRNSNet Asset Value(s)
18th Apr 20245:08 pmRNSTransaction in Own Shares
18th Apr 20243:44 pmRNSHolding(s) in Company
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 20245:20 pmRNSTransaction in Own Shares
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:43 pmRNSPortfolio Disclosures
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 202412:48 pmRNSNet Asset Value(s)
12th Apr 202412:56 pmRNSNet Asset Value(s)
12th Apr 202412:38 pmRNSDoc re. Half Yearly Report
11th Apr 202412:42 pmRNSNet Asset Value(s)
10th Apr 20245:21 pmRNSTransaction in Own Shares
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20245:17 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20244:38 pmRNSHolding(s) in Company
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:56 amRNSHolding(s) in Company
2nd Apr 202410:17 amRNSTotal Voting Rights
28th Mar 20242:04 pmRNSNet Asset Value(s)
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20244:04 pmRNSHolding(s) in Company
27th Mar 202412:19 pmRNSNet Asset Value(s)
26th Mar 202412:24 pmRNSNet Asset Value(s)
25th Mar 20243:58 pmRNSGearing disclosure
25th Mar 202412:06 pmRNSNet Asset Value(s)
22nd Mar 20245:13 pmRNSTransaction in Own Shares
22nd Mar 202412:16 pmRNSNet Asset Value(s)
21st Mar 20241:17 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.